TBXU ETF

TBXU ETF
$37.87
See how much of TBXU you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 15, 2026

Net Assets
$3M
Expense Ratio
0.98%
Dividend Yield (Current)
1.92%
Holdings
22
Inception Date
Oct 1, 2025
Fund Family
Direxion Shares ETF Trust
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD+28.94%

Asset Allocation

Stocks: 22.07%
Bonds: 2.18%
Cash: 17.43%
Other: 58.32%
See how much of TBXU you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
-Bioew5 Swap Asset Leg59.62%
-Bioew5 Swap Asset Leg46.24%
-Bioew5 Swap Asset Leg39.23%
DGCXXDreyfus Govt Cash Man Ins23.95%
FGTXXGoldman Finl Sq Trsry Inst 50619.41%
Top 10 Concentration: 243.36%Report Date: Sep 15, 2026
Download all 22 holdings for TBXU
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.92%
Frequency
Quarterly
Latest Distribution
$0.14
Sep 22, 2026
12M Distributions
5 payments
Total: $0.77

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

TBXU ETF Overview

TBXU ETF (Direxion Daily Biotech Top 5 Bull 2X ETF) is managed by Direxion Shares ETF Trust with $2.7M in net assets. TBXU expense ratio is 0.98%, holding 22 positions across sectors including Health Care, Financials. Inception date: 2025-10-01.

TBXU performance shows a YTD return of 28.94%.. TBXU dividend yield stands at 1.92%, paid quarterly.

TBXU top holdings include Bioew5 Swap Asset Leg (59.6%), Bioew5 Swap Asset Leg (46.2%), Bioew5 Swap Asset Leg (39.2%), Dreyfus Govt Cash Man Ins (23.9%), Goldman Finl Sq Trsry Inst 506 (19.4%). Go to all TBXU holdings, TBXU sectors, or TBXU dividends.

TBXU can be compared against other funds. Use TBXU overlap to find shared positions, or TBXU vs another fund for a side-by-side view. TBXU alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
-6.71%
YTD
+28.94%
1 Year
N/A
3 Year
N/A

Top 10 Holdings (net long exposure of 205% (≈2x))

#TickerNameSectorWeight
1-Bioew5 Swap Asset LegOther59.62%
2-Bioew5 Swap Asset LegOther46.24%
3-Bioew5 Swap Asset LegOther39.23%
4DGCXXDreyfus Govt Cash Man InsFinancials23.95%
5FGTXXGoldman Finl Sq Trsry Inst 506Unknown19.41%
6REGNRegeneron Pharmaceuticals, Inc.Health Care12.24%
7VRTXNvaesrtex Pharmaceuticals IncHealth Care11.03%
8GILDGilead SciencesHealth Care11.02%
9ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)Health Care10.46%
10AMGNAmgen Inc.Health Care10.16%